[IKT] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -27.21%
YoY- 68.49%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 698 38 220 271 240 124 167 158.35%
PBT -1,208 -671 -422 -547 -430 -1,212 -2,344 -35.59%
Tax -2,841 -664 -414 -540 -422 -1,205 -2,339 13.77%
NP -1,208 -671 -422 -547 -430 -1,212 -2,344 -35.59%
Tax Rate - - - - - - - -
Total Cost 1,906 708 641 818 670 1,337 2,511 -16.71%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -172.95 -1,779.72 -192.12 -202.17 -178.97 -974.37 -1,404.30 -75.08%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.87 -0.49 -0.31 -0.40 -0.32 -0.89 -1.72 -36.38%
EPS Diluted -0.87 -0.49 -0.31 -0.40 -0.32 -0.89 -1.72 -36.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.